Yuansheng Hu

发表

Safety, immunogenicity, and lot-to-lot consistency of live attenuated varicella vaccine in 1-3 years old children: a double-blind, randomized phase III trial

P. Qiu, Xiaoyu Cui, Li-yong Yuan, 2019, Human vaccines & immunotherapeutics.

Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction

J. Xia, Ling Wang, Zhiwei Jiang, 2020, Human vaccines & immunotherapeutics.

A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly

J. Xia, Q. Ye, Jing Li, 2018, Human vaccines & immunotherapeutics.

A comparative analysis of immunogenicity and safety of an enterovirus 71 vaccine between children aged 3-5 years and infants aged 6-35 months

Yangwenjie Wang, Jing-xin Li, Yuemei Hu, 2018, Expert review of vaccines.

Two-year efficacy and immunogenicity of Sinovac Enterovirus 71 vaccine against hand, foot and mouth disease in children

Jing-xin Li, F. Zhu, Yuemei Hu, 2016, Expert review of vaccines.

Safety and immunogenicity following a homologous booster dose of CoronaVac in children and adolescents

Z. Ying, Jing Li, Q. Gao, 2022, Nature Communications.

Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trial

K. Chu, Changgui Li, H. Pan, 2022, Human vaccines & immunotherapeutics.

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

K. Chu, Xiangxi Wang, Changgui Li, 2020, The Lancet Infectious Diseases.

Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China.

Wenbo Xu, Nan Wang, Zhenglun Liang, 2014, The New England journal of medicine.

A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine

Youming Zhou, Jing Li, Fangjun Li, 2017, The Pediatric infectious disease journal.

Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, Randomized, double-blind, placebo-controlled Trial.

Zhenglun Liang, J. Xia, Rong-cheng Li, 2014, The Journal of infectious diseases.

Immunogenicity and Safety of a Booster Dose of Live Attenuated Varicella Vaccine, and Immune Persistence of a Primary Dose for Children Aged 2 to 6 Years

Lei Wang, Fanhong Meng, N. Jia, 2022, Vaccines.

Effect of maternal antibody on the infant immune response to inactivated poliovirus vaccines made from Sabin strains

K. Chu, F. Zhu, Jian-feng Wang, 2019, Human vaccines & immunotherapeutics.

Five-year antibody persistence in children after one dose of inactivated or live attenuated hepatitis A vaccine

Zhilun Zhang, Jiang-ting Chen, Xiang-jun Zhu, 2017, Human vaccines & immunotherapeutics.

Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis

Jing-xin Li, F. Zhu, Yuemei Hu, 2021, Expert review of vaccines.

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III clinical trial in children aged 6–35 months in China

K. Chu, Changgui Li, Ming Shao, 2020, Human vaccines & immunotherapeutics.

Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial

K. Chu, Xiangxi Wang, B. Kan, 2020, medRxiv.

Immunogenicity and Safety of One versus Two Doses of Quadrivalent Inactivated Influenza Vaccine (IIV4) in Vaccine-Unprimed Children and One Dose of IIV4 in Vaccine-Primed Children Aged 3–8 Years

K. Chu, Yuansheng Hu, R. Tang, 2023, Vaccines.